Saito M - Search Results

1

Hereditary Motor and Sensory Neuropathy with Proximal Dominant Involvement: Clinical, Pathological, and Genetic Features.

Nakagawa M, Takashima H, Suehara M, Saito M, Saito A, Kanzato N, Matsuzaki T, Hirata K, Izumo S, Terwilliger JD, Osame M. Nakagawa M, et al. Among authors: saito m, saito a. Ann N Y Acad Sci. 1999 Oct;883(1):449-452. doi: 10.1111/j.1749-6632.1999.tb08607.x. Ann N Y Acad Sci. 1999. PMID: 29086967 No abstract available.

2

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis.

Matsuzaki T, Saito M, Usuku K, Nose H, Izumo S, Arimura K, Osame M. Matsuzaki T, et al. Among authors: saito m. J Neurol Sci. 2005 Oct 15;237(1-2):75-81. doi: 10.1016/j.jns.2005.05.011. J Neurol Sci. 2005. PMID: 15961107 Clinical Trial.

3

Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.

Saito A, Higuchi I, Nakagawa M, Saito M, Hirata K, Suehara M, Yoshida Y, Takahashi T, Aoki M, Osame M. Saito A, et al. Among authors: saito m. Acta Neuropathol. 2002 Dec;104(6):615-20. doi: 10.1007/s00401-002-0593-x. Epub 2002 Jul 19. Acta Neuropathol. 2002. PMID: 12410383 Review.

4

Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis.

Saito M, Higuchi I, Saito A, Izumo S, Usuku K, Bangham CR, Osame M. Saito M, et al. Among authors: saito a. J Infect Dis. 2002 Nov 1;186(9):1231-41. doi: 10.1086/344315. Epub 2002 Oct 7. J Infect Dis. 2002. PMID: 12402192

5

Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.

Saito M, Nakagawa M, Kaseda S, Matsuzaki T, Jonosono M, Eiraku N, Kubota R, Takenouchi N, Nagai M, Furukawa Y, Usuku K, Izumo S, Osame M. Saito M, et al. J Infect Dis. 2004 Jan 1;189(1):29-40. doi: 10.1086/380101. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702150 Clinical Trial.

6

Genetic variability in the extracellular matrix protein as a determinant of risk for developing HTLV-I-associated neurological disease.

Nobuhara Y, Usuku K, Saito M, Izumo S, Arimura K, Bangham CR, Osame M. Nobuhara Y, et al. Among authors: saito m. Immunogenetics. 2006 Jan;57(12):944-52. doi: 10.1007/s00251-005-0075-0. Epub 2006 Jan 10. Immunogenetics. 2006. PMID: 16402214

7

Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Saito M, Nose H, Usuku K, Sabouri AH, Matsuzaki T, Izumo S, Arimura K, Osame M. Saito M, et al. J Neurol Sci. 2006 Jul 15;246(1-2):37-43. doi: 10.1016/j.jns.2006.02.004. Epub 2006 Mar 6. J Neurol Sci. 2006. PMID: 16545396

8

Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.

Penova M, Kawaguchi S, Yasunaga JI, Kawaguchi T, Sato T, Takahashi M, Shimizu M, Saito M, Tsukasaki K, Nakagawa M, Takenouchi N, Hara H, Matsuura E, Nozuma S, Takashima H, Izumo S, Watanabe T, Uchimaru K, Iwanaga M, Utsunomiya A, Tabara Y, Paul R, Yamano Y, Matsuoka M, Matsuda F. Penova M, et al. Among authors: saito m. Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2004199118. doi: 10.1073/pnas.2004199118. Proc Natl Acad Sci U S A. 2021. PMID: 33649182 Free PMC article.

9

Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.

Nose H, Saito M, Usuku K, Sabouri AH, Matsuzaki T, Kubota R, Eiraku N, Furukawa Y, Izumo S, Arimura K, Osame M. Nose H, et al. Among authors: saito m. J Neurovirol. 2006 Jun;12(3):171-7. doi: 10.1080/13550280600827336. J Neurovirol. 2006. PMID: 16877298

10

Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.

Saito M, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, Sabouri AH, Izumo S, Arimura K, Osame M. Saito M, et al. J Neurol Sci. 2004 Apr 15;219(1-2):157-61. doi: 10.1016/j.jns.2004.01.009. J Neurol Sci. 2004. PMID: 15050452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,393 results

Search Page

Filters